Arquer Diagnostics
North East Business and Innovation Centre
Enterprise Park East
Wearfield
Sunderland
SR5 2TA
United Kingdom
Tel: 44-0-191-516-6765
Website: http://www.arquerdx.com/
About Arquer Diagnostics
Arquer Diagnostics (Arquer) is a private, UK based diagnostics company focused on the development and commercialisation of a non-invasive immunoassay diagnostic test for bladder and prostate cancer.YEAR FOUNDED:
2007
LEADERSHIP:
CEO: Nadia Whittley
CTO: Sarah Couch
JOBS:
Please click here for Arquer job opportunities.
FOLLOW ARQUER DIAGNOSTICS:
Tweets by Arquer Diagnostics
5 articles about Arquer Diagnostics
-
Arquer Diagnostics' ADXBLADDER Becomes First Bladder Cancer Urine Test To Undergo Rigorous Clinical Trials In USA
7/27/2021
ADXBLADDER has become the first new generation urinary biomarker test for bladder cancer to undergo rigorous clinical trials in the USA in decades.
-
New Hope For Women With Suspected Endometrial Cancer As Arquer Diagnostics' Innovative Urine Test Rules Out Disease In Up To 99% Of Cases
2/3/2021
For the first time, a simple, innovative test which uses patented technology to detect the cancer biomarker MCM5 in the urine, could help gynaecologists rule out endometrial cancer in as little as three hours.
-
Arquer Diagnostics Completes Patient Recruitment For MCM5 Clinical Trial
3/13/2017
-
Arquer Diagnostics Awarded Funding Under Innovate UK’s Biocatalyst Programme
3/1/2017
-
Arquer Diagnostics Taps a New CEO
12/1/2016